STADA and Alvotech Secure Approval for Uzpruvo, Europe's : c

Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within gastroenterology,...

Related Keywords

United Kingdom , South Korea , Yangtze River , China General , China , Taiwan , Vietnam , Republic Of , New Zealand , Hong Kong , India , Bad Vilbel , Hessen , Germany , United States , Indonesia , Liechtenstein , Norway , Iceland , Israel , Thailand , Cambodia , Japan , Malaysia , Pakistan , Philippines , Bangladesh , Singapore , Robert Wessman , Bryan Kim , Saval Latin America , Africa , Yangtze River Pharmaceutical Group Co Ltd , European Medicines Agency , Teva Pharmaceuticals , Committee For Medicinal Products Human Use , Alvotech Holdings , Global Communications , European Union Eu Member States , European Commission , Lotus Pharmaceuticals Co Ltd , Fuji Pharma Co Ltd Japan , Linkedin , Pharma Corporation Canada , Teva Pharmaceutical Industries Ltd , Oaktree Acquisition Corp , Kamada Ltd , European Economic Area , Member States , European Supplementary Protection Certificate , Specialty Head , Chief Commercial Officer , Medicinal Products , Human Use , South America , Teva Pharmaceutical Industries , Advanz Pharma , Cipla Med Pro , Yangtze River Pharmaceutical , Middle East , North Africa , Abdi Ibrahim , Mega Labs , Latin America , Private Securities Litigation Reform Act , Oaktree Acquisition , Note Regarding Forward Looking , Creditor Relations , Investor Relations , Nasdaq Alvo , Alvotech , Biosimilars , Iologics , Pharmaceuticals ,